Press releases

- Brain Researcher Monique Breteler appointed to the Royal Netherlands Academy

DZNE neuroepidemiologist honored for her research on dementia. The election recognizes her outstanding academic work and international scientific leadership.

Read more

- Cancer drug alleviates learning and memory problems in mice

Researchers in Göttingen have identified a cancer drug as a prototype drug that may be used to treat Alzheimer’s disease. This substance, known as “Vorinostat”, was found to alleviate learning and memory problems in mice.

Read more

- Overlooked for 30 years: a new kid on the block

A team led by Christian Haass has identified a novel peptide that plays a role in Alzheimer’s disease: The previously overlooked eta-amyloid interferes with neuronal function and may antogonize beta-amyloid – a finding that has implications for ongoing clinical trials.

Read more

- Mystery of polar bear Knut’s disease finally solved

The polar bear suffered from an autoimmune disease of the brain. This non-infectious illness is called “anti-NMDA receptor encephalitis”, with symptoms in human patients similar to those displayed by Knut. Knut is the first wild or domestic animal in which this form of…

Read more

- Award for a Pioneer of Alzheimer’s Research

British neuroscientist John Hardy will be awarded this year’s “Hartwig Piepenbrock-DZNE Prize” which is endowed with 60,000 Euro. Piepenbrock and the DZNE herewith honor his seminal contributions to the study of Alzheimer’s disease.

Read more

- MetLife Foundation Award: Munich-based DZNE researcher receives coveted US prize for medical research

[Translate to Englisch:]

Professor Christian Haass, site speaker at the DZNE in Munich, yesterday has been honored by MetLife Foundation in the USA at the Alzheimer’s Association International Conference in Washington DC. Haass, also director of the Adolf Butenandt Institute (chair of Metabolic…

Read more

- DZNE researcher becomes scientific leader of team developing national expert standard on "Nursing Care for People with Dementia"

The number of people in Germany who require nursing care has been rising steadily for years. Demographic developments indicate that this trend will continue. A parallel increase in the number of dementia patients is also being observed. These are important grounds for expert…

Read more

- Diabetes medication reduces dementia risk

Treating people with type 2 diabetes, also known as "age-related diabetes" with antidiabetics reduces their risk for Alzheimer’s and other types of dementia. The risk is most significantly reduced by the drug pioglitazone. Researchers of the DZNE draw this conclusion from an…

Read more

- 06/19/15 - DZNE and Bonn International School organize a "Young Researchers Day" for dementia research

On the activity day for primary school pupils at the Bonn International School (BIS), the DZNE gave around 150 children their first taste of the work of a research institution.

Read more

- DZNE Researchers find speedometer in the brain

Researchers in Bonn have identified neural circuits in the brains of mice that are pivotal for movement and navigation in space. These nerve cells that are presumed to exist in a similar form in humans, give the start signal for locomotion and also supply the brain with…

Read more

Welcome to our website, here you can inform yourself basically cookie-free.

We would be pleased if you would allow a cookie to be set for analysis purposes in order to optimise our provided information. All data are pseudonymous and are only used by the DZNE. We deliberately avoid third-party cookies. You can deselect this setting at any time here.

Your browser allows the setting of cookies: